Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS3W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,838
Award facts
- Contract value 100% obligated
- $62,837.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $62,837.88 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 MG/24 ML vials. This is a firm fixed-price, non-set-aside contract with a completion date of January 8, 2026, and was awarded on December 16, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA. The company supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. OPDIVO is a oncology medication, reflecting AmerisourceBergen's role in supplying specialized pharmaceutical treatments to military and federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FQS3W?
SPE2DR26FQS3W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQS3W worth?
The government has obligated $62,838 on SPE2DR26FQS3W.
Is contract SPE2DR26FQS3W an order under another contract?
Yes. SPE2DR26FQS3W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS3W competed?
The extent of competition for SPE2DR26FQS3W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award